Invion Share Price and Company Fundamentals



Price
$0.021
Change
0.001 (5.000%)
52 week
0.008 - 0.034

Last traded: Today at 5:10 AM

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a chlorophyll-based photosensitizer to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

24.09

Dividend yield

Beta

2.17

Market cap

-

Enterprise value

-

Company profile

Primary activitiesClinical-stage pharmaceutical drug development
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Websitehttps://www.inviongroup.com
Mailing address100 Albert Road Level 4 Melbourne VIC 3205 Australia
Phone / Fax61 3 9692 7222 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Invion does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Invion.

NameTitleAgeTotal Pay
Mr. Thian ChewCEO & Exec. Chairman311.85k
Ms. Melanie Jaye Leydin B.Bus, C.A., CAChief Financial Officer48
Dr. Dean NaylorHead of Intellectual Property Devel.
Ms. Claire Newstead-Sinclair BBus, C.A., CACompany Sec.

Profitability and management effectiveness

Profit margin

-63.64%

Operating margin

-67.48%

Return on assets

-17.24%

Return on equity

-29.01%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Invion is and its enterprise value is .

The IVX's stocks Beta value is 2.17 making it 117% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Invion (IVX)

Invion (ASX:IVX) Frequently Asked Questions

1. What is Invion's Stock Symbol?

Invion trades on ASX under the ticker symbol "IVX".

2. What is Invion's stock price today?

One share of IVX stock can currently be purchased for approximately $0.021.

3. How can I contact Invion?

Invion's mailing address is 100 Albert Road Level 4 Melbourne VIC 3205 Australia. The company can be reached via phone at 61 3 9692 7222.

4. What is Invion's official website?

The official website of Invion is https://www.inviongroup.com.

5. Which share registry manages Invion's stock?

Invion's stock is managed by LINK MARKET SERVICES LIMITED.